GlaxoSmithKline sees third quarter earnings beat forecasts thanks to strong demand for HIV drugs and flu vaccines
![GlaxoSmithKline sees third quarter earnings beat forecasts thanks to strong demand for HIV drugs and flu vaccines](http://i.dailymail.co.uk/i/pix/2015/10/28/14/1B190ECE000005DC-0-image-a-71_1446042941728.jpg)
Britain's biggest drugmaker saw its sales rise 9 per cent to £6.13billion in the three months to September 30, beating analysts’ consensus forecasts for £6.08billion.